InvestorsHub Logo
Followers 269
Posts 8494
Boards Moderated 0
Alias Born 10/05/2010

Re: SmittyInvestor post# 223

Monday, 01/31/2022 10:23:47 AM

Monday, January 31, 2022 10:23:47 AM

Post# of 278
Excellent post agree 100%.

Is it high risk...absolutely...if the regulators even get a whiff of Martin being involved in this in any way, it could be a disaster....but...with high risk comes the potential for high reward.

Leronlimab seems to draw a LOT of investor interest, take that interest and combine it with the microscopic float of RGMP.... and just simply due to the law of supply and demand.... the pps could fly.

I don't know what's going on with Martins stake in Phoenixus, sooner he's bought out the better as far as I'm concerned....but as long as he stays out of RGMP business, I like the odds.